|
ATP5S expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.2462035543831E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.09140532354036E-11 |
| Normal-vs-Stage2 |
1.09450000174149E-08 |
| Normal-vs-Stage3 |
3.28499999979748E-07 |
| Normal-vs-Stage4 |
1.69750000000857E-06 |
| Stage1-vs-Stage2 |
5.602200E-01 |
| Stage1-vs-Stage3 |
9.367800E-01 |
| Stage1-vs-Stage4 |
6.153600E-01 |
| Stage2-vs-Stage3 |
5.310600E-01 |
| Stage2-vs-Stage4 |
9.293000E-01 |
| Stage3-vs-Stage4 |
5.747000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70530273130498E-11 |
| Normal-vs-AfricanAmerican |
7.57400000495068E-08 |
| Normal-vs-Asian |
1.603880E-04 |
| Caucasian-vs-AfricanAmerican |
3.213000E-01 |
| Caucasian-vs-Asian |
7.940400E-01 |
| AfricanAmerican-vs-Asian |
5.589400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2912004798693E-11 |
| Normal-vs-Female |
5.58639999814758E-08 |
| Male-vs-Female |
8.077700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.18120000014832E-07 |
| Normal-vs-Extreme_Weight |
4.03379996072317E-10 |
| Normal-vs-Obese |
3.4739999765776E-09 |
| Normal-vs-Extreme_Obese |
7.85370000000452E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.587200E-01 |
| Normal_Weight-vs-Obese |
9.899800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.935200E-01 |
| Extreme_Weight-vs-Obese |
5.590600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.848000E-01 |
| Obese-vs-Extreme_Obese |
7.223600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.09140000000585E-05 |
| Normal-vs-Age(41-60Yrs) |
1.04909999576464E-08 |
| Normal-vs-Age(61-80Yrs) |
1.55719881433924E-11 |
| Normal-vs-Age(81-100Yrs) |
2.9165000003939E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.927200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.783000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.365160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.647960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.460150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.539600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.30304664228242E-12 |
| Normal-VS-Type2 PRCC |
4.4369999896432E-09 |
| Normal-VS-KIRP CIMP |
2.153400E-04 |
| Normal-VS-Unclassified PRCC |
8.53719983595624E-10 |
| Type1 PRCC-VS-Type2 PRCC |
8.463200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.652400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.493200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.869200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.441000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.023400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62334598488678E-12 |
| Normal-vs-N1 |
4.36059999997518E-06 |
| Normal-vs-N2 |
3.4093000000901E-07 |
| N0-vs-N1 |
1.510620E-01 |
| N0-vs-N2 |
1.097690E-02 |
| N1-vs-N2 |
9.863800E-03 |
|
|
